Long-term use of GLP-1 receptor agonists (e.g., Ozempic, Wegovy) for weight loss commonly causes persistent gastrointestinal issues like nausea, vomiting, and constipation. Significant, lasting effects include muscle mass loss, gallbladder disease, potential pancreatitis, and rapid facial fat loss (”Ozempic face”).
GoodRx
GoodRx
+4
Key Long-Term Side Effects and Risks
Persistent Gastrointestinal Distress: While GI symptoms often subside, many users experience lasting nausea, diarrhea, or constipation.
Muscle Loss (Sarcopenia): Significant reduction in body weight often includes loss of lean muscle mass, which can affect metabolic health.
“Ozempic Face” & Skin Changes: Rapid weight loss causes sagging, wrinkles, or thinner-looking skin on the face.
Gallbladder Problems: Increased risk of gallstones and gallbladder inflammation.
Pancreatitis: Potential risk of pancreatic inflammation.
Nutrient Deficiencies: Drastically reduced appetite may lead to, or worsen, nutritional gaps.
Hair Loss: Some users experience alopecia (hair thinning).
Weight Regain: High likelihood of regaining weight once the medication is stopped.
Rare/Potential Risks: Emerging research is looking into potential links to thyroid cancers, vision-related complications (retinopathy), and psychiatric issues like depression or suicidal ideation in specific individuals.
Harvard Health
Harvard Health
+9
Mitigation Strategies
Resistance Exercise: Crucial to counteract muscle loss.
High Protein Intake: To help maintain lean muscle.
Hydration: Essential, particularly when suffering from gastrointestinal discomfort
the issue that scares me the most about GLP-1s is the possibility of long-term gastroparesis AFTER GLP-1 consumption has ceased ...
[i know someone who developed that condition (not from GLP-1s), and it almost destroyed her life] ...